Ruoyu He

1.2k total citations
34 papers, 1.1k citations indexed

About

Ruoyu He is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Ruoyu He has authored 34 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Organic Chemistry and 5 papers in Oncology. Recurrent topics in Ruoyu He's work include Catalytic C–H Functionalization Methods (8 papers), Synthesis and Catalytic Reactions (6 papers) and Ubiquitin and proteasome pathways (5 papers). Ruoyu He is often cited by papers focused on Catalytic C–H Functionalization Methods (8 papers), Synthesis and Catalytic Reactions (6 papers) and Ubiquitin and proteasome pathways (5 papers). Ruoyu He collaborates with scholars based in China, United States and Macao. Ruoyu He's co-authors include Congyang Wang, Qi‐Yu Zheng, Zhi‐Tang Huang, Hui Chen, Jianjun Xi, Rangxiao Zhuang, Chongyang Zhao, Jiankang Zhang, Huajian Zhu and Limin Kong and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Organic Letters.

In The Last Decade

Ruoyu He

33 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruoyu He China 16 796 234 173 64 53 34 1.1k
Takuya Ishii Japan 18 1.2k 1.4× 111 0.5× 150 0.9× 46 0.7× 22 0.4× 62 1.6k
Klaus Nickisch United States 20 506 0.6× 118 0.5× 318 1.8× 68 1.1× 17 0.3× 86 1.0k
Jicheng Wu China 18 699 0.9× 126 0.5× 228 1.3× 87 1.4× 12 0.2× 49 1.2k
Ruhua Chen China 18 231 0.3× 96 0.4× 187 1.1× 95 1.5× 43 0.8× 32 699
Jane M. Donnelly Germany 4 321 0.4× 111 0.5× 137 0.8× 101 1.6× 55 1.0× 5 666
Chad M. Kormos United States 15 411 0.5× 83 0.4× 209 1.2× 100 1.6× 53 1.0× 35 802
Jinqian Liu United States 16 527 0.7× 37 0.2× 386 2.2× 38 0.6× 80 1.5× 29 1.1k
Elena Cini Italy 17 402 0.5× 145 0.6× 331 1.9× 30 0.5× 16 0.3× 47 672
Cynthia Licona France 12 292 0.4× 98 0.4× 147 0.8× 91 1.4× 18 0.3× 12 572
Steven J. Mehrman United States 7 569 0.7× 305 1.3× 326 1.9× 43 0.7× 6 0.1× 11 774

Countries citing papers authored by Ruoyu He

Since Specialization
Citations

This map shows the geographic impact of Ruoyu He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruoyu He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruoyu He more than expected).

Fields of papers citing papers by Ruoyu He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruoyu He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruoyu He. The network helps show where Ruoyu He may publish in the future.

Co-authorship network of co-authors of Ruoyu He

This figure shows the co-authorship network connecting the top 25 collaborators of Ruoyu He. A scholar is included among the top collaborators of Ruoyu He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruoyu He. Ruoyu He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Bin, et al.. (2024). Accurate projector calibration based on an improved sub-pixel homography mapping method of circular edge points. Optics and Lasers in Engineering. 186. 108768–108768.
2.
Wang, Yanfei, et al.. (2023). Single-cell analysis identifies phospholysine phosphohistidine inorganic pyrophosphate phosphatase as a target in ulcerative colitis. World Journal of Gastroenterology. 29(48). 6222–6234. 1 indexed citations
3.
Xi, Jianjun, Yu Cao, Ruoyu He, et al.. (2023). Design, Synthesis and Biological Evaluation of Glycosylated Derivatives of Silibinin as Potential Anti-Tumor Agents. Drug Design Development and Therapy. Volume 17. 2063–2076. 3 indexed citations
5.
Qiao, Tong, et al.. (2023). Morroniside Delays NAFLD Progression in Fructose-Fed Mice by Normalizing Lipid Metabolism and Inhibiting the Inflammatory Response. Journal of Food Biochemistry. 2023. 1–13. 5 indexed citations
6.
Jacobs, Ryan, Hao Wei, Xiaoshan Li, et al.. (2022). Performance and limitations of deep learning semantic segmentation of multiple defects in transmission electron micrographs. Cell Reports Physical Science. 3(5). 100876–100876. 30 indexed citations
7.
Shi, Tingting, Rangxiao Zhuang, Jianjun Xi, et al.. (2021). Regulation of Mitochondrial Function by Natural Products for the Treatment of Metabolic Associated Fatty Liver Disease. Canadian Journal of Gastroenterology and Hepatology. 2021(1). 5527315–5527315. 7 indexed citations
9.
Zhao, Yanmei, Lei Xu, Jiankang Zhang, et al.. (2020). Optimization of piperidine constructed peptidyl derivatives as proteasome inhibitors. Bioorganic & Medicinal Chemistry. 29. 115867–115867. 3 indexed citations
10.
Cao, Yu, Huajian Zhu, Ruoyu He, et al.. (2020). <p>Proteasome, a Promising Therapeutic Target for Multiple Diseases Beyond Cancer</p>. Drug Design Development and Therapy. Volume 14. 4327–4342. 21 indexed citations
11.
Zhang, Chong, Huajian Zhu, Jiaan Shao, et al.. (2020). Immunoproteasome-Selective Inhibitors: The Future of Autoimmune Diseases?. Future Medicinal Chemistry. 12(4). 269–272. 19 indexed citations
12.
Xi, Jianjun, Rangxiao Zhuang, Limin Kong, et al.. (2019). Immunoproteasome-selective inhibitors: An overview of recent developments as potential drugs for hematologic malignancies and autoimmune diseases. European Journal of Medicinal Chemistry. 182. 111646–111646. 36 indexed citations
13.
Zhang, Jiankang, Jianjun Xi, Ruoyu He, et al.. (2019). Discovery of 3-(thiophen/thiazole-2-ylthio)pyridine derivatives as multitarget anticancer agents. Medicinal Chemistry Research. 28(10). 1633–1647. 6 indexed citations
14.
Zhao, Yanmei, Jiankang Zhang, Rangxiao Zhuang, et al.. (2017). Synthesis and evaluation of a series of pyridine and pyrimidine derivatives as type II c-Met inhibitors. Bioorganic & Medicinal Chemistry. 25(12). 3195–3205. 16 indexed citations
15.
Zhuang, Rangxiao, Lixin Gao, Xiaoqing Lv, et al.. (2016). Exploration of novel piperazine or piperidine constructed non-covalent peptidyl derivatives as proteasome inhibitors. European Journal of Medicinal Chemistry. 126. 1056–1070. 11 indexed citations
16.
Lin, Dongdong, Ruxi Qi, Shujie Li, et al.. (2016). Interaction Dynamics in Inhibiting the Aggregation of Aβ Peptides by SWCNTs: A Combined Experimental and Coarse-Grained Molecular Dynamic Simulation Study. ACS Chemical Neuroscience. 7(9). 1232–1240. 28 indexed citations
17.
Zhao, Chongyang, et al.. (2016). Iron‐Carbonyl‐Catalyzed Redox‐Neutral [4+2] Annulation of N−H Imines and Internal Alkynes by C−H Bond Activation. Angewandte Chemie. 128(17). 5354–5357. 19 indexed citations
18.
He, Ruoyu, Zhi‐Tang Huang, Qi‐Yu Zheng, & Congyang Wang. (2014). Manganese‐Catalyzed Dehydrogenative [4+2] Annulation of NH Imines and Alkynes by CH/NH Activation. Angewandte Chemie. 126(19). 5050–5053. 112 indexed citations
19.
He, Ruoyu, Zhi‐Tang Huang, Qi‐Yu Zheng, & Congyang Wang. (2014). Manganese‐Catalyzed Dehydrogenative [4+2] Annulation of NH Imines and Alkynes by CH/NH Activation. Angewandte Chemie International Edition. 53(19). 4950–4953. 314 indexed citations
20.
He, Ruoyu, Zhi‐Tang Huang, Qi‐Yu Zheng, & Congyang Wang. (2014). Isoquinoline skeleton synthesis via chelation-assisted C−H activation. Tetrahedron Letters. 55(42). 5705–5713. 150 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026